Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
GZPHF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $1,924,594 | $11,827,223 | $14,510,832 | $18,273,150 |
| Short-Term Investments | $649,189 | $0 | $4,029,884 | $0 |
| Receivables | $3,510,595 | $24,175,027 | $23,995,691 | $20,449,402 |
| Inventory | $1,555,669 | $11,316,985 | $10,822,921 | $12,811,902 |
| Other Curr. Assets | $755,573 | $10,156,723 | $1,572,632 | $5,649,831 |
| Total Curr. Assets | $8,484,905 | $58,234,275 | $55,673,034 | $57,762,228 |
| Property Plant & Equip (Net) | $1,148,564 | $8,117,519 | $7,950,560 | $7,937,612 |
| Goodwill | $117,102 | $834,091 | $834,091 | $830,855 |
| Intangibles | $449,411 | $3,209,937 | $3,210,887 | $3,198,697 |
| Long-Term Investments | $1,255,043 | $1,466,260 | $10,646,288 | $0 |
| Tax Assets | $168,576 | $1,254,949 | $1,218,548 | $1,210,404 |
| Other NC Assets | $52,919 | $9,302,624 | $514,391 | $10,743,816 |
| Total NC Assets | $3,191,615 | $24,185,380 | $24,374,765 | $23,921,383 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $11,676,520 | $82,419,655 | $80,047,799 | $81,683,612 |
| Liabilities | – | – | – | – |
| Payables | $1,809,868 | $17,504,139 | $16,410,953 | $16,319,521 |
| Short-Term Debt | $2,398,836 | $10,265,096 | $9,005,028 | $9,122,982 |
| Tax Payable | $0 | $464,287 | $516,475 | $248,911 |
| Deferred Revenue | $121,856 | $0 | $0 | $0 |
| Other Curr. Liab. | $750,550 | $3,600,430 | $4,305,831 | $7,250,862 |
| Total Curr. Liab. | $5,298,405 | $37,859,235 | $36,108,911 | $38,915,689 |
| LT Debt | $464,997 | $2,580,551 | $2,097,912 | $2,805,539 |
| Deferred Rev, NC | $140,630 | $985,092 | $1,014,770 | $1,001,862 |
| Deferred Tax Liab, NC | $86,901 | $645,629 | $625,148 | $625,557 |
| Other NC Liab. | $16,449 | $118,452 | $118,586 | $119,613 |
| Total NC Liab. | $764,571 | $4,749,186 | $4,299,969 | $4,998,286 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $419,462 | $443,553 | $445,715 |
| Total Liabilities | $6,062,976 | $42,608,421 | $40,408,880 | $43,913,976 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $228,252 | $1,625,791 | $1,625,791 | $1,625,791 |
| Retained Earnings | $3,344,869 | $23,681,161 | $23,636,650 | $21,815,337 |
| AOCI | $1,748,722 | $0 | $0 | $0 |
| Other Equity | $0 | $3,397,829 | $12,456,597 | $3,407,123 |
| Total Equity | $5,321,843 | $37,760,172 | $37,719,038 | $35,904,528 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $291,701 | $2,051,062 | $1,919,882 | $1,865,108 |
| Total Liab. & Tot. Equity | $11,676,520 | $82,419,655 | $80,047,799 | $81,683,612 |
| Net Debt | $939,239 | $1,018,424 | -$3,407,892 | -$6,344,629 |